Navegação por Autor "Ramjattan, Brian"
Resultados 1-2 de 2
-
Determinants of acquisition and clearance of human papillomavirus infection in previously unexposed young women
El-Zein, Mariamt; Ramanakumar, Agnihotram V.; Naud, Paulo Sergio Viero; Martins, Cecilia M. Rotelli; Carvalho, Newton S. de; Borba, Paola Colares de; Teixeira, Júlio César; Moscicki, A. B.; Harper, Diane M.; Tyring, Stephen K.; Ramjattan, Brian; Dubin, Gary; Franco, Eduardo Luis Fabiano; HPV-007 Study Group (2019) [Artigo de periódico]Background Global variation in human papillomavirus (HPV) prevalence and persistence may be explained by differences in risk factors, such as sexual activity, oral contraceptive use, and behavioral factors. We evaluated ... -
Post Hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA
Struyf, Frank; Colau, Brigitte; Wheeler, Cosette M.; Naud, Paulo Sergio Viero; Garland, Suzanne M.; Quint, Wim G. V.; Chow, Song-Nan; Salmerón, Jorge; Lehtinen, Matti; Del Rosario-Raymundo, Maria Rowena; Paavonen, Jorma; Teixeira, Júlio César; Germar, Maria Julieta V.; Peters, Klaus; Skinner, S. Rachel; Limson, Genara; Castellsague, Xavier; Poppe, Willy A. J.; Ramjattan, Brian; Klein, Terry D.; Schwarz, Tino F.; Chatterjee, Archana; Tjalma, Wiebren A. A.; Diaz-Mitoma, Francisco; Lewis, David J. M.; Harper, Diane M.; Molijn, Anco; Doorn, Leen-Jan van; David, Marie-Pierre; Dubin, Gary; HPV PATRICIA Study Group (2015) [Artigo de periódico]The efficacy of the human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against cervical infections with HPV in the Papilloma Trial against Cancer in Young Adults (PATRICIA) was evaluated using a combination ...